Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphoprotein Phosphatases | 5 | 2020 | 328 | 1.330 |
Why?
|
| PTEN Phosphohydrolase | 7 | 2020 | 1111 | 1.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2019 | 2455 | 0.920 |
Why?
|
| RNA Editing | 1 | 2022 | 149 | 0.750 |
Why?
|
| Juniperus | 1 | 2019 | 3 | 0.670 |
Why?
|
| Cytostatic Agents | 1 | 2019 | 9 | 0.660 |
Why?
|
| Receptors, Purinergic P2X7 | 5 | 2018 | 86 | 0.660 |
Why?
|
| Cell Death | 2 | 2024 | 1676 | 0.600 |
Why?
|
| Receptors, Purinergic P2X | 1 | 2017 | 9 | 0.570 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 419 | 0.540 |
Why?
|
| Nuclear Proteins | 4 | 2020 | 5782 | 0.520 |
Why?
|
| Carrier Proteins | 3 | 2022 | 4935 | 0.510 |
Why?
|
| Plant Extracts | 1 | 2019 | 496 | 0.500 |
Why?
|
| Stem Cells | 2 | 2020 | 3517 | 0.460 |
Why?
|
| Heptanoic Acids | 3 | 2014 | 344 | 0.430 |
Why?
|
| Prostatic Neoplasms | 4 | 2022 | 11101 | 0.390 |
Why?
|
| Receptors, Purinergic P2X4 | 3 | 2020 | 21 | 0.380 |
Why?
|
| Hepatocytes | 1 | 2017 | 1231 | 0.340 |
Why?
|
| Pyrroles | 3 | 2014 | 1124 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2915 | 0.310 |
Why?
|
| Adenosine Triphosphate | 2 | 2014 | 1988 | 0.300 |
Why?
|
| Toluene 2,4-Diisocyanate | 2 | 2018 | 10 | 0.280 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 374 | 0.280 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1963 | 0.260 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2018 | 201 | 0.260 |
Why?
|
| Inflammation | 1 | 2024 | 10759 | 0.230 |
Why?
|
| Lysophospholipids | 2 | 2018 | 337 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2020 | 736 | 0.230 |
Why?
|
| Receptor, EphB2 | 1 | 2023 | 26 | 0.230 |
Why?
|
| Proteins | 1 | 2019 | 5993 | 0.230 |
Why?
|
| Receptor, EphB4 | 1 | 2023 | 39 | 0.220 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2023 | 56 | 0.210 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2024 | 753 | 0.200 |
Why?
|
| RNA, Small Interfering | 5 | 2020 | 3412 | 0.200 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 3245 | 0.170 |
Why?
|
| Ornithine Decarboxylase | 1 | 2019 | 63 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2023 | 521 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2020 | 3590 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2014 | 2881 | 0.160 |
Why?
|
| Phosphorylation | 5 | 2018 | 8300 | 0.150 |
Why?
|
| Clusterin | 1 | 2018 | 71 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2023 | 16952 | 0.150 |
Why?
|
| Biophysical Phenomena | 1 | 2019 | 321 | 0.150 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2017 | 152 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 630 | 0.130 |
Why?
|
| Epithelial Cells | 3 | 2024 | 3671 | 0.130 |
Why?
|
| Tight Junctions | 1 | 2018 | 324 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 1893 | 0.130 |
Why?
|
| Actins | 1 | 2022 | 2046 | 0.120 |
Why?
|
| Deoxycytidine | 1 | 2019 | 878 | 0.120 |
Why?
|
| Transfection | 2 | 2020 | 5748 | 0.120 |
Why?
|
| Eosinophils | 1 | 2019 | 951 | 0.120 |
Why?
|
| Fluorouracil | 1 | 2019 | 1642 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3788 | 0.110 |
Why?
|
| Thioguanine | 1 | 2013 | 45 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 826 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.100 |
Why?
|
| Endometriosis | 1 | 2020 | 870 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2527 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1703 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2013 | 364 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 6124 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10422 | 0.080 |
Why?
|
| DNA Primers | 1 | 2014 | 2814 | 0.080 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 382 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3201 | 0.080 |
Why?
|
| Cell Movement | 3 | 2018 | 5195 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 150 | 0.080 |
Why?
|
| Cell Survival | 1 | 2019 | 5778 | 0.080 |
Why?
|
| Humans | 19 | 2024 | 761208 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2018 | 23416 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2010 | 411 | 0.080 |
Why?
|
| Apoptosis | 1 | 2024 | 9477 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2017 | 2846 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 13402 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 2864 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2015 | 1490 | 0.070 |
Why?
|
| Protein Binding | 1 | 2019 | 9297 | 0.070 |
Why?
|
| Gene Expression | 1 | 2019 | 7571 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5032 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8530 | 0.060 |
Why?
|
| Male | 9 | 2024 | 360693 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2015 | 1910 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6919 | 0.050 |
Why?
|
| Base Sequence | 1 | 2014 | 12404 | 0.050 |
Why?
|
| Animals | 8 | 2020 | 168079 | 0.050 |
Why?
|
| Insulin | 1 | 2017 | 6588 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7571 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2011 | 193 | 0.040 |
Why?
|
| Chemical Industry | 1 | 2018 | 116 | 0.040 |
Why?
|
| Rats | 1 | 2014 | 23704 | 0.040 |
Why?
|
| beta Catenin | 1 | 2023 | 1042 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 1083 | 0.030 |
Why?
|
| Caveolin 1 | 1 | 2018 | 255 | 0.030 |
Why?
|
| Lung | 1 | 2015 | 9979 | 0.030 |
Why?
|
| Occupational Exposure | 2 | 2018 | 1814 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2023 | 1333 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2020 | 526 | 0.030 |
Why?
|
| Female | 7 | 2024 | 392544 | 0.030 |
Why?
|
| ROC Curve | 1 | 2023 | 3584 | 0.030 |
Why?
|
| Astrocytoma | 1 | 2019 | 774 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 452 | 0.030 |
Why?
|
| Cell Line | 2 | 2019 | 15545 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1867 | 0.030 |
Why?
|
| Estrogens | 1 | 2020 | 1522 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 1379 | 0.020 |
Why?
|
| Leukocytes | 1 | 2019 | 2025 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20982 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3551 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10756 | 0.020 |
Why?
|
| Mice | 4 | 2020 | 81326 | 0.020 |
Why?
|
| Microglia | 1 | 2019 | 1358 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2010 | 166 | 0.020 |
Why?
|
| Prostate | 1 | 2018 | 1772 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13632 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14392 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2010 | 283 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 229 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 361 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 430 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 231 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2011 | 899 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2816 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4111 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1005 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 1495 | 0.020 |
Why?
|
| Glioma | 1 | 2019 | 3452 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12728 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3577 | 0.010 |
Why?
|
| Genotype | 1 | 2018 | 12985 | 0.010 |
Why?
|
| Adolescent | 2 | 2023 | 88298 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2018 | 3758 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9416 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6312 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2925 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2011 | 4137 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11509 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 42224 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18220 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22127 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 59221 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 3702 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15920 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29687 | 0.010 |
Why?
|
| Child | 1 | 2023 | 80152 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 24021 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 39957 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 220853 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 221119 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 22140 | 0.000 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_